Implementing a claims-based algorithm and disease management program may be an effective strategy to reduce relapse and cost among patients with schizophrenia.
Heidi C. Waters, PhD, MBA
Advertisement
Articles by Heidi C. Waters, PhD, MBA
Advertisement
Latest Updated Articles
- A Claims-Based Algorithm to Reduce Relapse and Cost in Schizophrenia
Published: December 12th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx
5
